Hemophilia without prophylaxis: Assessment of joint range of

Clinical outcome and incidence of inhibitor development in severe hemophilia patients receiving low-dose prophylaxis: a 3-year follow-up study in Senegal, West Africa

The frequency of joint hemorrhages and procedures in nonsevere hemophilia A vs B - ScienceDirect

Treatment patterns and bleeding outcomes in persons with severe hemophilia A and B in a real-world setting

Manual and educational therapy in the treatment of hemophilic arthropathy of the elbow: a randomized pilot study, Orphanet Journal of Rare Diseases

PDF] Guidelines for the management of haemophilia in Egypt

Resolution of Target Joints (TJs) in Children with Severe Haemophilia A (HA) Treated with Turoctocog Alfa Pegol (N8-GP) Prophylaxis: Results from the Pathfinder 5 Trial - ISTH Congress Abstracts

The bleeding phenotype in people with nonsevere hemophilia - ScienceDirect

Managing Chronic Pain in Patients with Hemophilia

Ultrasound Assessment of the Joint Status in Hemophilia Patients under Prophylaxis Using the Hemophilia Early Arthropathy Detection with Ultrasound (HEAD-US) Score - ISTH Congress Abstracts

Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1-4 studies - ScienceDirect

Frontiers Exploration of the minimum necessary FVIII level at different physical activity levels in pediatric patients with hemophilia A

PDF) Emicizumab Prophylaxis in Hemophilia A with Inhibitors